Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

150 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Application of pharmacogenomics to investigate adverse drug reactions to the disease-modifying treatments for multiple sclerosis: a case-control study protocol for dimethyl fumarate-induced lymphopenia.
Kowalec K, Kingwell E, Carruthers R, Marrie RA, Bernatsky S, Traboulsee A, Ross CJD, Carleton B, Tremlett H. Kowalec K, et al. Among authors: carruthers r. BMJ Open. 2017 Jun 2;7(5):e016276. doi: 10.1136/bmjopen-2017-016276. BMJ Open. 2017. PMID: 28576902 Free PMC article.
Effects of physical comorbidities on disability progression in multiple sclerosis.
Zhang T, Tremlett H, Zhu F, Kingwell E, Fisk JD, Bhan V, Campbell T, Stadnyk K, Carruthers R, Wolfson C, Warren S, Marrie RA; CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis. Zhang T, et al. Among authors: carruthers r. Neurology. 2018 Jan 30;90(5):e419-e427. doi: 10.1212/WNL.0000000000004885. Epub 2018 Jan 3. Neurology. 2018. PMID: 29298855 Free PMC article.
Advanced imaging findings in progressive solitary sclerosis: a single lesion or a global disease?
Lee LE, Chan JK, Nevill E, Soares A, Vavasour IM, MacMillan EL, Garren H, Clayton D, Keegan BM, Tam R, Traboulsee AL, Kolind SH, Carruthers RL. Lee LE, et al. Among authors: carruthers rl. Mult Scler J Exp Transl Clin. 2019 Jan 16;5(1):2055217318824612. doi: 10.1177/2055217318824612. eCollection 2019 Jan-Mar. Mult Scler J Exp Transl Clin. 2019. PMID: 30729027 Free PMC article.
Effect of different doses of gadolinium contrast agent on clinical outcomes in MS.
Ackermans N, Taylor C, Tam R, Carruthers R, Kolind S, Kang H, Freedman MS, Li DK, Traboulsee AL. Ackermans N, et al. Among authors: carruthers r. Mult Scler J Exp Transl Clin. 2019 Feb 16;5(1):2055217318823796. doi: 10.1177/2055217318823796. eCollection 2019 Jan-Mar. Mult Scler J Exp Transl Clin. 2019. PMID: 30800415 Free PMC article.
Best Practices for Long-Term Monitoring and Follow-Up of Alemtuzumab-Treated MS Patients in Real-World Clinical Settings.
Barclay K, Carruthers R, Traboulsee A, Bass AD, LaGanke C, Bertolotto A, Boster A, Celius EG, de Seze J, Cruz DD, Habek M, Lee JM, Limmroth V, Meuth SG, Oreja-Guevara C, Pagnotta P, Vos C, Ziemssen T, Baker DP, Wijmeersch BV. Barclay K, et al. Among authors: carruthers r. Front Neurol. 2019 Mar 22;10:253. doi: 10.3389/fneur.2019.00253. eCollection 2019. Front Neurol. 2019. PMID: 30967831 Free PMC article. Review.
150 results